Literature DB >> 11097034

Cloning and expression of gene fragment IgA-binding protein of group B streptococci.

I Ustinovitch1, G Vlasov, A Totolyan, A Suvorov.   

Abstract

Different fragments of the bac gene coding for the IgA-binding protein were cloned, sequenced and expressed in E. coli. Cloning was accomplished after amplification of different parts of the gene by PCR. The 1.5-kb fragment of the gene was cloned using plasmid pBluescript. This fragment coded for the 45-kDa protein with the stable expression of IgA binding. In order to verify the exact location of the IgA-binding domain two smaller plasmids were constructed. Both plasmids were prepared using pQE30 (31, 32) expression vectors from Qiagen. The plasmids carried 245 and 123 bp bac gene fragments encoding 14- and 7-kDa proteins. These proteins together with the 20-amino-acid oligopeptide ITNEDKDSMLKKIEDINRQA were tested for IgA binding. Only the 14-kDa protein was able to bind IgA. This protein was used for rabbit immunization and found to be immunogenic. The data obtained lead to the conclusion that there is a lower limit in the size of recombinant IgA-binding proteins that can be utilized for anti-GBS vaccination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11097034     DOI: 10.1007/BF02825670

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  4 in total

1.  Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity.

Authors:  L O Hedén; E Frithz; G Lindahl
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

2.  The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions.

Authors:  P G Jerlström; G S Chhatwal; K N Timmis
Journal:  Mol Microbiol       Date:  1991-04       Impact factor: 3.501

3.  Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci.

Authors:  P G Jerlström; S R Talay; P Valentin-Weigand; K N Timmis; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Comparative genetic study of group B streptococcal strains of human and bovine origin.

Authors:  A Dmitriev; L Tkáciková; A Suvorov; M Kantíková; I Mikula; A Totolyan
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

  4 in total
  5 in total

1.  Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci.

Authors:  A Dmitriev; E Shakleina; L Tkáciková; I Mikula; A Totolian
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

2.  Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity.

Authors:  E I Vorobieva; L F Meringova; G F Leontieva; K B Grabovskaya; A N Suvorov
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

3.  Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides.

Authors:  Yulia A Desheva; Galina F Leontieva; Tatiana A Kramskaya; Tatiana A Smolonogina; Kornelia B Grabovskaya; Irina V Kiseleva; Larisa G Rudenko; Alexander N Suvorov
Journal:  Open Microbiol J       Date:  2016-10-31

4.  Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.

Authors:  Yulia A Desheva; Galina F Leontieva; Tatiana A Kramskaya; Tatiana A Smolonogina; Kornelia B Grabovskaya; Galina O Landgraf; Vadim E Karev; Alexander N Suvorov; Larisa G Rudenko
Journal:  Virology (Auckl)       Date:  2017-06-06

5.  Development of experimental GBS vaccine for mucosal immunization.

Authors:  T Gupalova; G Leontieva; T Kramskaya; K Grabovskaya; E Bormotova; D Korjevski; A Suvorov
Journal:  PLoS One       Date:  2018-05-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.